Manipulating gene expression in the mature inner ear

Brain Research

Volumn 1091, Issue 1, 2006, Pages 265-269

  Crumling, Mark A ^a   Raphael, Yehoash ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Cochlea; Gene expression; Gene therapy; Gene transfer; Hereditary deafness; Inner ear; Regeneration; Viral vector

Indexed keywords

ADENOVIRUS VECTOR; GROWTH FACTOR; LENTIVIRUS VECTOR; PARVOVIRUS VECTOR; VIRUS PROTEIN; VIRUS VECTOR;

ARTICLE; CELL PROLIFERATION; COCHLEA; COCHLEA PROSTHESIS; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; GENE TRANSFER; GENE VECTOR; GENETIC DISORDER; GENETIC MANIPULATION; GENOME; HAIR CELL; HEARING IMPAIRMENT; HUMAN; IN VIVO STUDY; INNER EAR; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; TRANSGENE; TREATMENT OUTCOME; UPREGULATION; VIRAL GENE THERAPY;

ANIMALS; EAR, INNER; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; HUMANS; TRANSDUCTION, GENETIC;

EID: 33745625827     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.01.075     Document Type: Article

References (58)

1. Amalfitano A. Use of multiply deleted adenovirus vectors to probe adenovirus vector performance and toxicities. Curr. Opin. Mol. Ther. 5 (2003) 362-366
2. Avraham K.B., and Raphael Y. Prospects for gene therapy in hearing loss. J. Basic Clin. Physiol. Pharmacol. 14 (2003) 77-83
3. 2+/calmodulin-dependent protein kinase II by RNA interference. Mol. Ther. 11 (2005) 899-905
4. Bowers W.J., Chen X., Guo H., Frisina D.R., Federoff H.J., and Frisina R.D. Neurotrophin-3 transduction attenuates Cisplatin spiral ganglion neuron ototoxicity in the cochlea. Mol. Ther. 6 (2002) 12-18
5. Branda C.S., and Dymecki S.M. Talking about a revolution: the impact of site-specific recombinases on genetic analyses in mice. Dev. Cell 6 (2004) 7-28
6. Brough D.E., Hsu C., Kulesa V.A., Lee G.M., Cantolupo L.J., Lizonova A., and Kovesdi I. Activation of transgene expression by early region 4 is responsible for a high level of persistent transgene expression from adenovirus vectors in vivo. J. Virol. 71 (1997) 9206-9213
7. Burton E.A., Fink D.J., and Glorioso J.C. Replication-defective genomic HSV gene therapy vectors: design, production and CNS applications. Curr. Opin. Mol. Ther. 7 (2005) 326-336
8. Caplen N.J. RNAi as a gene therapy approach. Expert Opin. Biol. Ther. 3 (2003) 575-586
9. Chen P., and Segil N. p27(Kip1) links cell proliferation to morphogenesis in the developing organ of Corti. Development 126 (1999) 1581-1590
10. Chen X., Frisina R.D., Bowers W.J., Frisina D.R., and Federoff H.J. HSV amplicon-mediated neurotrophin-3 expression protects murine spiral ganglion neurons from cisplatin-induced damage. Mol. Ther. 3 (2001) 958-963
11. Corey D.P., Garcia-Anoveros J., Holt J.R., Kwan K.Y., Lin S.Y., Vollrath M.A., Amalfitano A., Cheung E.L., Derfler B.H., Duggan A., Geleoc G.S., Gray P.A., Hoffman M.P., Rehm H.L., Tamasauskas D., and Zhang D.S. TRPA1 is a candidate for the mechanosensitive transduction channel of vertebrate hair cells. Nature 432 (2004) 723-730
12. El-Andaloussi S., Holm T., and Langel U. Cell-penetrating peptides: mechanisms and applications. Curr. Pharm. Des. 11 (2005) 3597-3611
13. Hart S.L. Lipid carriers for gene therapy. Curr. Drug Delivery 2 (2005) 423-428
14. Ishimoto S., Kawamoto K., Kanzaki S., and Raphael Y. Gene transfer into supporting cells of the organ of Corti. Hear. Res. 173 (2002) 187-197
15. Ishimoto S., Kawamoto K., Stover T., Kanzaki S., Yamasoba T., and Raphael Y. A glucocorticoid reduces adverse effects of adenovirus vectors in the cochlea. Audiol. Neuro-Otol. 8 (2003) 70-79
16. Izumikawa M., Minoda R., Kawamoto K., Abrashkin K.A., Swiderski D.L., Dolan D.F., Brough D.E., and Raphael Y. Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat. Med. 11 (2005) 271-276
17. Kanzaki S., Stover T., Kawamoto K., Prieskorn D.M., Altschuler R.A., Miller J.M., and Raphael Y. Glial cell line-derived neurotrophic factor and chronic electrical stimulation prevent VIII cranial nerve degeneration following denervation. J. Comp. Neurol. 454 (2002) 350-360
18. Kawamoto K., Ishimoto S., Minoda R., Brough D.E., and Raphael Y. Math1 gene transfer generates new cochlear hair cells in mature guinea pigs in vivo. J. Neurosci. 23 (2003) 4395-4400
19. Kawamoto K., Yagi M., Stover T., Kanzaki S., and Raphael Y. Hearing and hair cells are protected by adenoviral gene therapy with TGF-beta1 and GDNF. Mol. Ther. 7 (2003) 484-492
20. Kawamoto K., Sha S.H., Minoda R., Izumikawa M., Kuriyama H., Schacht J., and Raphael Y. Antioxidant gene therapy can protect hearing and hair cells from ototoxicity. Mol. Ther. 9 (2004) 173-181
21. Kerem B., Rommens J.M., Buchanan J.A., Markiewicz D., Cox T.K., Chakravarti A., Buchwald M., and Tsui L.C. Identification of the cystic fibrosis gene: genetic analysis. Science 245 (1989) 1073-1080
22. Kitamura K., Takahashi K., Tamagawa Y., Noguchi Y., Kuroishikawa Y., Ishikawa K., and Hagiwara H. Deafness genes. J. Med. Dent. Sci. 47 (2000) 1-11
23. Kos C.H. Cre/loxP system for generating tissue-specific knockout mouse models. Nutr. Rev. 62 (2004) 243-246
24. Lalwani A.K., and Mhatre A.N. Cochlear gene therapy. Ear Hear. 24 (2003) 342-348
25. Lalwani A.K., Han J.J., Walsh B.J., Zolotukhin S., Muzyczka N., and Mhatre A.N. Green fluorescent protein as a reporter for gene transfer studies in the cochlea. Hear. Res. 114 (1997) 139-147
26. Lee Y.B., Glover C.P., Cosgrave A.S., Bienemann A., and Uney J.B. Optimizing regulatable gene expression using adenoviral vectors. Exp. Physiol. 90 (2005) 33-37
27. Liang Y., Wang A., Probst F.J., Arhya I.N., Barber T.D., Chen K.S., Deshmukh D., Dolan D.F., Hinnant J.T., Carter L.E., Jain P.K., Lalwani A.K., Li X.C., Lupski J.R., Moeljopawiro S., Morell R., Negrini C., Wilcox E.R., Winata S., Camper S.A., and Friedman T.B. Genetic mapping refines DFNB3 to 17p11.2, suggests multiple alleles of DFNB3, and supports homology to the mouse model shaker-2. Am. J. Hum. Genet. 62 (1998) 904-915
28. Liu X., Jiang Q., Mansfield S.G., Puttaraju M., Zhang Y., Zhou W., Cohn J.A., Garcia-Blanco M.A., Mitchell L.G., and Engelhardt J.F. Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing. Nat. Biotechnol. 20 (2002) 47-52
29. Liu X., Luo M., Zhang L.N., Yan Z., Zak R., Ding W., Mansfield S.G., Mitchell L.G., and Engelhardt J.F. Spliceosome-mediated RNA trans-splicing with recombinant adeno-associated virus partially restores cystic fibrosis transmembrane conductance regulator function to polarized human cystic fibrosis airway epithelial cells. Hum. Gene Ther. 16 (2005) 1116-1123
30. Lowenheim H., Furness D.N., Kil J., Zinn C., Gultig K., Fero M.L., Frost D., Gummer A.W., Roberts J.M., Rubel E.W., Hackney C.M., and Zenner H.P. Gene disruption of p27(Kip1) allows cell proliferation in the postnatal and adult organ of corti. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 4084-4088
31. Maeda Y., Fukushima K., Nishizaki K., and Smith R.J. In vitro and in vivo suppression of GJB2 expression by RNA interference. Hum. Mol. Genet. 14 (2005) 1641-1650
32. Manoharan M. RNA interference and chemically modified siRNAs. Nucleic Acids Res. (2003) 115-116
33. Martin P.E., Coleman S.L., Casalotti S.O., Forge A., and Evans W.H. Properties of connexin26 gap junctional proteins derived from mutations associated with non-syndromal hereditary deafness. Hum. Mol. Genet. 8 (1999) 2369-2376
34. Nagy A. Cre recombinase: the universal reagent for genome tailoring. Genesis 26 (2000) 99-109
35. Nakagawa S., Massie B., and Hawley R.G. Tetracycline-regulatable adenovirus vectors: pharmacologic properties and clinical potential. Eur. J. Pharm. Sci. 13 (2001) 53-60
36. Noureddini S.C., and Curiel D.T. Genetic targeting strategies for adenovirus. Mol. Pharmacol. 2 (2005) 341-347
37. Ohyama T., and Groves A.K. Generation of Pax2-Cre mice by modification of a Pax2 bacterial artificial chromosome. Genesis 38 (2004) 195-199
38. Patel N.P., Mhatre A.N., and Lalwani A.K. Biological therapy for the inner ear. Expert Opin. Biol. Ther. 4 (2004) 1811-1819
39. Probst F.J., Fridell R.A., Raphael Y., Saunders T.L., Wang A., Liang Y., Morell R.J., Touchman J.W., Lyons R.H., Noben-Trauth K., Friedman T.B., and Camper S.A. Correction of deafness in shaker-2 mice by an unconventional myosin in a BAC transgene. Science 280 (1998) 1444-1447
40. Puttaraju M., Jamison S.F., Mansfield S.G., Garcia-Blanco M.A., and Mitchell L.G. Spliceosome-mediated RNA trans-splicing as a tool for gene therapy. Nat. Biotechnol. 17 (1999) 246-252
41. Rabionet R., Lopez-Bigas N., Arbones M.L., and Estivill X. Connexin mutations in hearing loss, dermatological and neurological disorders. Trends Mol. Med. 8 (2002) 205-212
42. Rodin S., and Georgiev P. Handling three regulatory elements in one transgene: combined use of cre-lox, FLP-FRT, and I-Scel recombination systems. Biotechniques 39 (2005) 871-876
43. Rossi F.M., and Blau H.M. Recent advances in inducible gene expression systems. Curr. Opin. Biotechnol. 9 (1998) 451-456
44. Rouan F., White T.W., Brown N., Taylor A.M., Lucke T.W., Paul D.L., Munro C.S., Uitto J., Hodgins M.B., and Richard G. trans-dominant inhibition of connexin-43 by mutant connexin-26: implications for dominant connexin disorders affecting epidermal differentiation. J. Cell Sci. 114 (2001) 2105-2113
45. Sage C., Huang M., Karimi K., Gutierrez G., Vollrath M.A., Zhang D.S., Garcia-Anoveros J., Hinds P.W., Corwin J.T., Corey D.P., and Chen Z.Y. Proliferation of functional hair cells in vivo in the absence of the retinoblastoma protein. Science 307 (2005) 1114-1118
46. Shou J., Zheng J.L., and Gao W.Q. Robust generation of new hair cells in the mature mammalian inner ear by adenoviral expression of Hath1. Mol. Cell. Neurosci. 23 (2003) 169-179
47. Sorrell D.A., and Kolb A.F. Targeted modification of mammalian genomes. Biotechnol. Adv. 23 (2005) 431-469
48. Staecker H., Gabaizadeh R., Federoff H., and Van De Water T.R. Brain-derived neurotrophic factor gene therapy prevents spiral ganglion degeneration after hair cell loss. Otolaryngol.-Head Neck Surg. 119 (1998) 7-13
49. Stone I.M., Lurie D.I., Kelley M.W., and Poulsen D.J. Adeno-associated virus-mediated gene transfer to hair cells and support cells of the murine cochlea. Mol. Ther. 11 (2005) 843-848
50. Stover T., Yagi M., and Raphael Y. Cochlear gene transfer: round window versus cochleostomy inoculation. Hear. Res. 136 (1999) 124-130
51. Stover T., Yagi M., and Raphael Y. Transduction of the contralateral ear after adenovirus-mediated cochlear gene transfer. Gene Ther. 7 (2000) 377-383
52. Suzuki M., Yagi M., Brown J.N., Miller A.L., Miller J.M., and Raphael Y. Effect of transgenic GDNF expression on gentamicin-induced cochlear and vestibular toxicity. Gene Ther. 7 (2000) 1046-1054
53. Tomar R.S., Matta H., and Chaudhary P.M. Use of adeno-associated viral vector for delivery of small interfering RNA. Oncogene 22 (2003) 5712-5715
54. White S.M., Renda M., Nam N.Y., Klimatcheva E., Zhu Y., Fisk J., Halterman M., Rimel B.J., Federoff H., Pandya S., Rosenblatt J.D., and Planelles V. Lentivirus vectors using human and simian immunodeficiency virus elements. J. Virol. 73 (1999) 2832-2840
55. Wilson J.M. Adeno-associated virus and lentivirus pseudotypes for lung-directed gene therapy. Proc. Am. Thorac Soc. 1 (2004) 309-314
56. Xia H., Mao Q., Eliason S.L., Harper S.Q., Martins I.H., Orr H.T., Paulson H.L., Yang L., Kotin R.M., and Davidson B.L. RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat. Med. 10 (2004) 816-820
57. Yagi M., Magal E., Sheng Z., Ang K.A., and Raphael Y. Hair cell protection from aminoglycoside ototoxicity by adenovirus-mediated overexpression of glial cell line-derived neurotrophic factor. Hum. Gene Ther. 10 (1999) 813-823
58. Yagi M., Kanzaki S., Kawamoto K., Shin B., Shah P.P., Magal E., Sheng J., and Raphael Y. Spiral ganglion neurons are protected from degeneration by GDNF gene therapy. J. Assoc. Res. Otolaryngol. 1 (2000) 315-325